Today in session 4116 of the biennial World Ophthalmology Congress 2018 (WOC) in Barcelona:
Latest Developments in Gene Therapy for Retinal Disease
Monday June 18, 4pm, in hall 8, room 6 at the Congress Center in Fira Gran Via, Barcelona
Session Chairs: Botond Roska, Hugh Taylor, Hendrik Scholl
Presentations:
#7361 - Monitoring Progression and Developing Outcome Measures for Clinical Trials in Stargardt Disease: The ProgStar Study
Speaker Hendrik Scholl, MA, MD
#7632 - Gene Therapy in X-linked Juvenile Retinoschisis (XLRS)
Speaker Paul Sieving, MD, PhD
#7363 - Gene Therapy in Leber Hereditary Optic Neuropathy (LHON)
Speaker José-Alain Sahel, MD
#7364 - Gene Therapy in Achromatopsia
Speaker Eberhart Zrenner, MD
#7365 - Cell-type Specific Targeting in the Human Retina
Speaker Botond Roska, MD, PhD
Round Table Discussion
Speakers
Hendrik Scholl, MA, MD Paul Sieving, MD, PhD José-Alain Sahel, MD Eberhart Zrenner, MD Botond Roska, MD, PhD
https://www.wocabstracts.org/index.cfm?do=ev.viewEv&ev=5650